In Vivo Pre-clinical characterization of a Novel Series of FGFR2 Selective Inhibitors with Potency Against Clinically Relevant Mutations

被引：0

作者：

Fischer, J. ^{[1
]}

Bouhana, K. ^{[1
]}

Chicarelli, M. J. ^{[1
]}

Dahlke, J. ^{[1
]}

Fell, B. ^{[1
]}

Fulton, J. ^{[1
]}

Guarnieri, A. ^{[1
]}

Haygood, L. ^{[1
]}

Jalluri, R. ^{[1
]}

Johnson, A. ^{[1
]}

McLean, B. ^{[1
]}

Max, M. ^{[1
]}

Rieger, R. ^{[1
]}

Robinson, J. ^{[1
]}

Rodriguez, M. ^{[1
]}

Sullivan, F. ^{[1
]}

Wang, Y. ^{[1
]}

Winski, S. ^{[1
]}

Zhou, Y. ^{[1
]}

机构：

[1] Cogent Biosci, Res Dev, Boulder, CO USA

来源：

EUROPEAN JOURNAL OF CANCER | 2022年 / 174卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

227

引用

页码：S81 / S81

页数：1

共 46 条

[31] Discovery and characterization of highly potent and selective USP7 inhibitors and benchmarking against clinical MDM2 antagonists
Gavory, Gerald
O'Dowd, Colin
Arkoudis, Elias
Barker, Oliver
Cassidy, Eamon
Dossang, Anthony
Flasz, Jakub
Helm, Matt
Hughes, Caroline
McClelland, Keeva
Miel, Hugues
Odrzywol, Ewa
Page, Natalie
Harrison, Tim
CANCER RESEARCH, 2018, 78 (13)
[32] Heat shock protein 90 (hsp90) inhibitors: A novel class of agents with activity against Waldenstrom's macroglobulinemia (WM): Pre-clinical studies, and molecular profiling and clinical implications.
Mitsiades, CS
Mitsiades, N
McMullan, CJ
Poulaki, V
Shringarpure, R
Hideshima, T
Chauhan, D
Treon, SP
Richardson, PG
Munshi, NC
Joseph, M
Libermann, T
Anderson, K
BLOOD, 2003, 102 (11) : 648A - 648A
[33] Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis
Sun, Ronggai
Skeiky, Yasir A. W.
Izzo, Angelo
Dheenadhayalan, Veerabadran
Imam, Zakaria
Penn, Erica
Stagliano, Katherine
Haddock, Scott
Mueller, Stefanie
Fulkerson, John
Scanga, Charles
Grover, Ajay
Derrick, Steven C.
Morris, Sheldon
Hone, David M.
Horwitz, Marcus A.
Kaufmann, Stefan H. E.
Sadoff, Jerald C.
VACCINE, 2009, 27 (33) : 4412 - 4423
[34] The two novel BTK-inhibitors M2951 and M7583 show in vivo anti-tumor activity in pre-clinical models of B cell lymphoma
Gaudio, Eugenio
Tarantelli, Chiara
Zucca, Emanuele
Rossi, Davide
Stathis, Anastasios
Bertoni, Francesco
CANCER RESEARCH, 2017, 77
[35] Discovery of a series of dimethoxybenzene FGFR inhibitors with 5H-pyrrolo[2,3-b]pyrazine scaffold: structure–activity relationship, crystal structural characterization and in vivo study
Peng Wei
Bo Liu
Ruifeng Wang
Yinglei Gao
Lanlan Li
Yuchi Ma
Zhiwei Qian
Yuelei Chen
Maosheng Cheng
Meiyu Geng
Jingkang Shen
Dongmei Zhao
Jing Ai
Bing Xiong
ActaPharmaceuticaSinicaB, 2019, 9 (02) : 351 - 368
[36] Discovery of a series of dimethoxybenzene FGFR inhibitors with 5H-pyrrolo[2,3-b]pyrazine scaffold: structure-activity relationship, crystal structural characterization and and in vivo study
Wei, Peng
Liu, Bo
Wang, Ruifeng
Gao, Yinglei
Li, Lanlan
Ma, Yuchi
Qian, Zhiwei
Chen, Yuelei
Cheng, Maosheng
Geng, Meiyu
Shen, Jingkang
Zhao, Dongmei
Ai, Jing
Xiong, Bing
ACTA PHARMACEUTICA SINICA B, 2019, 9 (02) : 351 - 368
[37] VITRO AND IN VIVO CHARACTERIZATION OF EYP001 A NOVEL, POTENT AND SELECTIVE FXR AGONIST NOW IN A PHASE 2 CLINICAL TRIAL IN NASH
Radreau, Pauline
Joly, Stephane
Dubos, Claire
Vonderscher, Jacky
Scalfaro, Pietro
Meldrum, Eric
Darteil, Raphael
HEPATOLOGY, 2019, 70 : 1267A - 1267A
[38] A novel surfactant aided micellar system of oxidation inhibitors in clotrimazole bioadhesive gel: development, characterization, in vitro and in vivo antifungal evaluation against Candida clinical isolates
Bhardwaj, Varun
Monga, Jitender
Sharma, Amit
Sharma, Shailesh
Sharma, Arun
Sharma, Poonam
RSC ADVANCES, 2014, 4 (88): : 47207 - 47221
[39] Novel 5,10-dihydrobenzo[b][1,8]napthyridine N-oxides as non-nucleoside reverse transcriptase inhibitors of HIV-1 with high potency against clinically relevant mutants variants.
Johnson, BL
Tarby, CM
Srivastava, A
Bakthavatchalam, R
Lin, QY
Cocuzza, AJ
Bilder, DM
Bacheler, LT
Diamond, S
Jeffrey, S
Klabe, RM
Cordova, BC
Garber, S
Logue, K
Erickson-Viitanen, SK
Trainor, GL
Anderson, PS
Rodgers, JD
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U24 - U24
[40] SAR optimization studies on a novel series of 2-anilinopyrimidines as selective inhibitors against triple-negative breast cancer cell line MDA-MB-468
Jo, Jeyun
Kim, Heegyu
Oh, Ji Youn
Kim, Soyeong
Park, Yeong Hye
Choi, Hyeonjin
Jeong, Jee-Yeong
Jung, Young-Suk
Yun, Hwayoung
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (24)

← 1 2 3 4 5 →